Report to Congress: Coordinated Strategy to Accelerate Development of Vaccines for Infectious Diseases [open pdf - 1MB]
"The purpose of the Tom Lantos and Henry J. Hyde United States Global Leadership against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008, Public Law 110-293, is to strengthen and enhance U.S. leadership and the effectiveness of the U.S. response to the HIV/AIDS, tuberculosis, and malaria pandemics and other related and preventable infectious diseases as part of the overall U.S. health and development agenda. Section 206 of this law states: 'the President shall produce a comprehensive report, written by a study group of qualified professionals from relevant Federal agencies and initiatives, nongovernmental organizations, and industry representatives, that sets forth a coordinated strategy to accelerate development of vaccines for infectious diseases, such as HIV/AIDS, malaria, and tuberculosis, which includes: i. initiatives to create economic incentives for the research, development, and manufacturing of vaccines for HIV/AIDS, tuberculosis, malaria, and other infectious diseases; ii. an expansion of public-private partnerships and the leveraging of resources from other countries and the private sector; and iii. efforts to maximize United States capabilities to support clinical trials of vaccines in developing countries and to address the challenges of delivering vaccines in developing countries to minimize delays in access once vaccines are available.' This comprehensive report responds to this request. This report was compiled and edited by the congressionally mandated study group, which was set up for this purpose."
United States Agency for International Development: http://www.usaid.gov/